Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
about
Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: A reviewAn siRNA screen identifies RSK1 as a key modulator of lung cancer metastasisRole of E2-Ub-conjugating enzymes during skeletal muscle atrophyIdentification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolutionSunitinib in solid tumorsPerformance-enhancing substances in sports: a review of the literatureInternational Society of Sports Nutrition Position Stand: beta-hydroxy-beta-methylbutyrate (HMB)HMB supplementation: clinical and athletic performance-related effects and mechanisms of actionIron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiencyBeta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trialsNovel role for p90 ribosomal S6 kinase in the regulation of cardiac myofilament phosphorylationHypoxia-inducible factors in the kidneyβ-Hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged ratsMAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomasβ-Hydroxy β-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD ratLeucine and HMB differentially modulate proteasome system in skeletal muscle under different sarcopenic conditionsEvidence-based recommendations for natural bodybuilding contest preparation: nutrition and supplementationβ-hydroxy-β-methylbutyrate (HMB) prevents sepsis-induced diaphragm dysfunction in micep90 ribosomal S6 kinase 1 (RSK1) and the catalytic subunit of protein kinase A (PKA) compete for binding the pseudosubstrate region of PKAR1alpha: role in the regulation of PKA and RSK1 activities.The effects of omega-3 fatty acid supplementation on dexamethasone-induced muscle atrophy.Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma.Despite Inflammation, Supplemented Essential Amino Acids May Improve Circulating Levels of Albumin and Haemoglobin in Patients after Hip FracturesSelf-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.Novel treatments for cancer cachexia.Regulation of intracellular pH by p90Rsk-dependent activation of an Na(+)/H(+) exchanger in starfish oocytes.The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.Free acid gel form of β-hydroxy-β-methylbutyrate (HMB) improves HMB clearance from plasma in human subjects compared with the calcium HMB salt.Cord blood stem cells inhibit epidermal growth factor receptor translocation to mitochondria in glioblastoma.Vitamin D status affects strength gains in older adults supplemented with a combination of β-hydroxy-β-methylbutyrate, arginine, and lysine: a cohort study.Regulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNλ signalingEffect of oral nutritional supplementation on wound healing in diabetic foot ulcers: a prospective randomized controlled trialBeta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinaseAcute and timing effects of beta-hydroxy-beta-methylbutyrate (HMB) on indirect markers of skeletal muscle damageEffects of β-hydroxy-β-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats.Silencing of reversion-inducing cysteine-rich protein with Kazal motifs stimulates hyperplastic phenotypes through activation of epidermal growth factor receptor and hypoxia-inducible factor-2α.Immune Function and Muscle Adaptations to Resistance exercise in Older Adults: Study Protocol for a Randomized Controlled Trial of a Nutritional Supplement.The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migrationHypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1The efficacy of a β-hydroxy-β-methylbutyrate supplementation on physical capacity, body composition and biochemical markers in elite rowers: a randomised, double-blind, placebo-controlled crossover study
P2860
Q21245067-4EEEF0A2-31BD-4D0F-9B47-5CD94F832212Q24297829-4C59AD6C-2358-41AB-B835-B1C859D0FD9EQ26827979-7544A5E8-5828-49DC-A479-0754F2FFBEEBQ27676158-347A223B-128B-4B1E-8A3E-1F48E1A28942Q28245467-F45C1F90-019F-4C85-8348-8A87F4B93C77Q28256659-C92C7E82-0C89-4FCC-8A2C-309B8896931EQ28284730-A2FDD2D0-423D-41BE-B58A-028E4013A264Q28287244-FBC4E6D1-9D7C-4B85-A97D-57E0804368A4Q28297161-063F19A3-ED23-4E4C-89DC-D39E4363B59DQ28299062-17B6A91C-D49C-4A4F-90E2-333FFE130253Q28300397-BB91B943-7094-4874-A2B2-483135732639Q28303287-04D47960-8C3D-4EB5-98E1-D6CA75805C96Q28391990-2177C8B8-233B-4118-A047-1B813F8BE516Q28393224-DD5224F6-7828-4ECC-8064-00DB72C187B9Q28540883-C4D09B82-B6B2-41EB-BD59-CE9E285EE0B2Q28567279-F09BE9E8-EBAF-412B-A3F3-C1742898F9A3Q33661388-72600F16-D789-4ACA-9495-E142A36E1282Q33725222-CDE95EF2-635C-4E99-A002-967718008681Q33747936-4B5E63AA-55D2-4AD8-9918-E45BCA738555Q33748505-0EC66171-B2BD-43EF-B9F1-49FA5DC8E295Q33799049-18517BDA-D5A2-42CC-93C8-14860D319BB0Q33852230-ED58890C-0949-4A7C-A029-21D6E78D309EQ33972424-3A82AF28-C817-4201-9C63-A0CE9377C6E7Q34005616-D5ADE386-E0E6-4F46-9EAE-D774B61BEBD5Q34025231-38C70D58-22C2-4507-BEDF-A18995698A5FQ34031245-3D053164-6425-4EAF-99B4-9039792C47F3Q34153509-F867F76D-8CA2-404C-8155-A50790B7FA24Q34163778-4F71E4DA-E4B8-48BF-94F1-345274938B55Q34205375-212D7678-1C11-4AA1-AB40-2CDD3CB67F42Q34488887-15382331-6F66-40ED-A793-4F104AEC4A3CQ34516287-E0FC5AAC-F2EB-43A2-8E19-3E99AE872211Q34556525-80C6259A-BAB7-40C3-9F7D-962FD1B99847Q34578128-8C3C8086-20E4-4914-B4A7-510E34B0AB4EQ34604132-7ED81BA9-D786-44A5-8215-09FB9398D0E3Q34622685-2CCF24C0-17DF-4CE0-B3D4-6E3BBC666937Q35078415-8185F1B9-3E47-43C9-A86F-7BFCF1D9B075Q35544504-C6901C38-BF7D-4F99-AE43-C92AEBF9C646Q35879981-E86EBAC7-0C2D-4DF6-B1F6-126588084B99Q35882401-D0C30048-3673-49C5-A2BB-CEA96D4D8BDCQ35899270-7B9889B5-7F77-4FF7-8177-4CEB1A586B16
P2860
Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Attenuation of proteasome-indu ...... in cancer-induced muscle loss.
@ast
Attenuation of proteasome-indu ...... in cancer-induced muscle loss.
@en
type
label
Attenuation of proteasome-indu ...... in cancer-induced muscle loss.
@ast
Attenuation of proteasome-indu ...... in cancer-induced muscle loss.
@en
prefLabel
Attenuation of proteasome-indu ...... in cancer-induced muscle loss.
@ast
Attenuation of proteasome-indu ...... in cancer-induced muscle loss.
@en
P2093
P1433
P1476
Attenuation of proteasome-indu ...... in cancer-induced muscle loss.
@en
P2093
Helen J Smith
Michael J Tisdale
Pradip Mukerji
P304
P356
10.1158/0008-5472.CAN-05-0169
P407
P577
2005-01-01T00:00:00Z